Keith Goldan
Finanzdirektor/CFO bei SYNDAX PHARMACEUTICALS, INC.
Vermögen: 1 Mio $ am 31.05.2024
Profil
Keith Alan Goldan is the founder of Century Capital Associates.
He is currently the Treasurer, Chief Financial & Accounting Officer at Syndax Pharmaceuticals, Inc. (since 2023).
Previously, he held the position of Chief Financial Officer & Director at Realm Therapeutics Plc (2004-2008), CFO, Treasurer & Senior Vice President at Fibrocell Science, Inc. (2015-2017), Chief Financial Officer & Senior Vice President at NuPathe, Inc. (2013-2014), and Chief Financial Officer at OptiNose, Inc. (2017-2022).
He also served as the Chief Financial Officer & Vice President at Biosyn, Inc. and Chief Financial Officer at Cantel Medical (UK) Ltd.
Mr. Goldan obtained an undergraduate degree from the Robert H.
Smith School of Business and an MBA from The Wharton School of the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
14.06.2024 | 52 623 ( 0,06% ) | 1 Mio $ | 31.05.2024 |
Aktive Positionen von Keith Goldan
Unternehmen | Position | Beginn |
---|---|---|
SYNDAX PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 13.06.2022 |
Ehemalige bekannte Positionen von Keith Goldan
Unternehmen | Position | Ende |
---|---|---|
OPTINOSE, INC. | Finanzdirektor/CFO | 10.06.2022 |
FIBROCELL SCIENCE, INC. | Finanzdirektor/CFO | 01.01.2017 |
NUPATHE INC | Finanzdirektor/CFO | 21.02.2014 |
Cantel Medical (UK) Ltd.
Cantel Medical (UK) Ltd. Drugstore ChainsRetail Trade Cantel Medical (UK) Ltd. provides infection prevention products and services. It offers endoscopy procedure disposables, water purification systems, and healthcare disposables. The company was founded on March 10, 1992 and is headquartered in Stafford, the United Kingdom. | Finanzdirektor/CFO | 31.10.2008 |
REALM THERAPEUTICS PLC | Finanzdirektor/CFO | 13.10.2008 |
Ausbildung von Keith Goldan
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Robert H. Smith School of Business | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
OPTINOSE, INC. | Health Technology |
SYNDAX PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Cantel Medical (UK) Ltd.
Cantel Medical (UK) Ltd. Drugstore ChainsRetail Trade Cantel Medical (UK) Ltd. provides infection prevention products and services. It offers endoscopy procedure disposables, water purification systems, and healthcare disposables. The company was founded on March 10, 1992 and is headquartered in Stafford, the United Kingdom. | Retail Trade |
Realm Therapeutics Plc
Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Realm Therapeutics Plc engages in the development of novel therapeutics. It focuses on the prescription treatments for immune mediated diseases in adults and children. The company was founded on April 21, 2006 and is headquartered in Malvern, PA. | Health Technology |
Biosyn, Inc.
Biosyn, Inc. Pharmaceuticals: MajorHealth Technology Biosyn, Inc. operates as a pharmaceutical company that develops and commercializes drugs used to treat infectious disease and reproductive health. The company is headquartered in Philadelphia, PA. | Health Technology |
NuPathe, Inc.
NuPathe, Inc. Medical SpecialtiesHealth Technology NuPathe, Inc. develops pharmaceutical and therapeutic products. It focuses on the development and commercialization of branded therapeutics for diseases of central nervous system, including neurological and psychiatric disorders. The company was founded by Terri B. Sebree and Jane Holmes Hollingsworth in 2005 and is headquartered in Malvern, PA. | Health Technology |
Century Capital Associates | |
Fibrocell Science, Inc.
Fibrocell Science, Inc. Pharmaceuticals: MajorHealth Technology Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on December 28, 1995 and is headquartered in Exton, PA. | Health Technology |